Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities

Autor: Julia Seither, Pavan Mamidi, Mariana Blanco, Thomas Robinson, Alessia Melegaro, Mara Violato, Ana Luíza Gibertoni Cruz, Jorge Friedman, Matias Fuentes Becerra, Laurence Roope, Paolo Candio, Xinyang Hua, Peter John Loewen, Adrian G. Barnett, Jean-François Bonnefon, Juan F. Vargas, Raymond M. Duch, Philip Clarke
Přispěvatelé: Nuffield College, University of Oxford [Oxford], John Radcliffe Hospital [Oxford University Hospital], Universidad de Chile = University of Chile [Santiago] (UCHILE), Durham University, Toulouse School of Economics (TSE), Université Toulouse 1 Capitole (UT1), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-École des hautes études en sciences sociales (EHESS)-Centre National de la Recherche Scientifique (CNRS)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), University of Toronto, Ashoka University, Bocconi University [Milan, Italy], Universidad del Rosario [Bogota], University of Birmingham [Birmingham], The University of MelbourneParkville, VIC, Australia., Queensland University of Technology [Brisbane] (QUT)
Rok vydání: 2021
Předmět:
Adult
medicine.medical_specialty
COVID-19 Vaccines
Health Personnel
Social Sciences
Sample (statistics)
vaccinations
Public opinion
JEL: I - Health
Education
and Welfare/I.I1 - Health/I.I1.I18 - Government Policy • Regulation • Public Health

03 medical and health sciences
Patient safety
Politics
0302 clinical medicine
Surveys and Questionnaires
medicine
Humans
030212 general & internal medicine
B- ECONOMIE ET FINANCE
030304 developmental biology
0303 health sciences
Government
Multidisciplinary
Public economics
business.industry
SARS-CoV-2
Public health
Vaccination
public health
1. No poverty
COVID-19
[SHS.ECO]Humanities and Social Sciences/Economics and Finance
3. Good health
Public Opinion
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
COVID-19
PUBLIC HEALTH
PUBLIC OPINION
VACCINATIONS

business
Developed country
Zdroj: Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, 2021, Vol.118(38), pp.e2026382118 [Peer Reviewed Journal]
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2021, 118 (38), ⟨10.1073/pnas.2026382118⟩
ISSN: 1091-6490
0027-8424
DOI: 10.1073/pnas.2026382118⟩
Popis: Significance How to allocate COVID-19 vaccines is one of the most important decisions currently facing governments. With limited supplies, what is most pressing is deciding who gets priority in the vaccine allocation rollout. Some governments are exploring allowing private purchases of COVID-19 vaccines. Many countries are debating whether COVID-19 vaccines should be mandated. There is little evidence on what policies are preferred by the global public. Our survey of 15,536 adults in 13 countries confirms that priority should be given to health workers and those at high risk but also, to a broad range of key workers and those with lower incomes. The public favors allocating COVID-19 vaccines solely via government programs but was polarized in some countries on mandatory vaccinations.
How does the public want a COVID-19 vaccine to be allocated? We conducted a conjoint experiment asking 15,536 adults in 13 countries to evaluate 248,576 profiles of potential vaccine recipients who varied randomly on five attributes. Our sample includes diverse countries from all continents. The results suggest that in addition to giving priority to health workers and to those at high risk, the public favors giving priority to a broad range of key workers and to those with lower income. These preferences are similar across respondents of different education levels, incomes, and political ideologies, as well as across most surveyed countries. The public favored COVID-19 vaccines being allocated solely via government programs but were highly polarized in some developed countries on whether taking a vaccine should be mandatory. There is a consensus among the public on many aspects of COVID-19 vaccination, which needs to be taken into account when developing and communicating rollout strategies.
Databáze: OpenAIRE